Author:
Arifa Raquel D.N.,Madeira Mila F.M.,de Paula Talles P.,Lima Renata L.,Tavares Livia D.,Menezes-Garcia Zélia,Fagundes Caio T.,Rachid Milene A.,Ryffel Bernhard,Zamboni Dario S.,Teixeira Mauro M.,Souza Danielle G.
Funder
Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Subject
Pathology and Forensic Medicine
Reference55 articles.
1. Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin level;Boige;Eur J Cancer,2006
2. First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer;Park;Oncology,2004
3. First-line treatment with capecitabine combined with irinotecan in patients with advanced colorectal carcinoma: a phase II study;Assy;J Clin Gastroenterol,2012
4. Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions;Slatter;Drug Metab Dispos,1997
5. Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients;Slatter;Drug Metab Dispos,2000
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献